Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)
NCT ID: NCT02633904
Last Updated: 2015-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2015-12-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Osteotomy
Femoral osteotomy are applied in the open treatment of Developmental Dislocation of the Hip (DDH).
Osteotomy
Femoral osteotomy are applied in the open treatment of Developmental Dislocation of the Hip (DDH).
Non-osteotomy
Femoral osteotomy are not applied in the open treatment of Developmental Dislocation of the Hip (DDH).
Non-osteotomy
Femoral osteotomy are not applied in the open treatment of Developmental Dislocation of the Hip (DDH).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Osteotomy
Femoral osteotomy are applied in the open treatment of Developmental Dislocation of the Hip (DDH).
Non-osteotomy
Femoral osteotomy are not applied in the open treatment of Developmental Dislocation of the Hip (DDH).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Tonnis degree I or II.
3. Not receive any open treatment.
Exclusion Criteria
2. Patients with mental, neurological disorders (such as hypoxic-ischemic encephalopathy, epilepsy and dementia) or significant barriers to growth, cerebral palsy, multiple joint contractures disease, dysfunction of liver and kidney , blood disorders, immune deficiency disease and ECG abnormalities.
3. Any children with prior hip surgery were excluded from the series.
4. Parents refused further treatment.
18 Months
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hunan Children's Hospital
OTHER_GOV
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Guangzhou Women and Children's Medical Center
OTHER
Wuhan Women and Children's Medical Center
OTHER
Shenzhen Children's Hospital
OTHER_GOV
Foshan Hospital of Traditional Chinese Medicine
OTHER
He Jin Peng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
He Jin Peng
Resident doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fan J Shao, Doctor
Role: STUDY_DIRECTOR
Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Sankar WN, Tang EY, Moseley CF. Predictors of the need for femoral shortening osteotomy during open treatment of developmental dislocation of the hip. J Pediatr Orthop. 2009 Dec;29(8):868-71. doi: 10.1097/BPO.0b013e3181c29cb2.
Pospischill R, Weninger J, Ganger R, Altenhuber J, Grill F. Does open reduction of the developmental dislocated hip increase the risk of osteonecrosis? Clin Orthop Relat Res. 2012 Jan;470(1):250-60. doi: 10.1007/s11999-011-1929-4. Epub 2011 Jun 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
He Jin Peng
Identifier Type: REGISTRY
Identifier Source: secondary_id
FSODDH
Identifier Type: -
Identifier Source: org_study_id